CN Patent

CN102847136A — 抑制蛋白酶体的组合物

Assigned to Onyx Pharmaceuticals Inc · Expires 2013-01-02 · 13y expired

What this patent protects

本发明涉及抑制蛋白酶体的组合物。具体地，涉及包含一种或多种几乎不溶解的蛋白酶体抑制剂和环糊精，特别是取代环糊精的组合物，其显著增加了这些蛋白酶体抑制剂的溶解度并促进它们的给药。这些组合物任选包含缓冲剂。还公开了使用这些组合物的治疗方法。

USPTO Abstract

本发明涉及抑制蛋白酶体的组合物。具体地，涉及包含一种或多种几乎不溶解的蛋白酶体抑制剂和环糊精，特别是取代环糊精的组合物，其显著增加了这些蛋白酶体抑制剂的溶解度并促进它们的给药。这些组合物任选包含缓冲剂。还公开了使用这些组合物的治疗方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN102847136A
Jurisdiction
CN
Classification
—
Expires
2013-01-02
Drug substance claim
No
Drug product claim
No
Assignee
Onyx Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.